NextCure Inc (NXTC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $29.31M
Last updated: Nov 17, 2026 at 11:05 AM ET
NextCure Inc (NXTC) Stock Forecast
Analysts expect NextCure (NXTC) to earn -$6.34 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$5.90.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$6.34
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$5.90
- EPS consensus
- Next report
- Mar 3, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$6.34 | -$6.34 to -$6.34 | 1 |
| Dec 31, 2027 | -$5.90 | -$10.41 to -$1.38 | 2 |
Quarterly Estimates
The EPS consensus falls from -$1.44 for the quarter ending Dec 31, 2026 to -$2.23 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.44 | -$1.98 to -$0.83 | 4 |
| Mar 31, 2027 | -$2.23 | -$2.23 to -$2.23 | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$6.93.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$6.34 | -$6.26 | -$7.46 | -$7.32 | -$6.93 | N/A |
| Fiscal year ending Dec 31, 2027 | -$5.90 | -$5.76 | -$7.07 | -$8.31 | -$8.35 | N/A |
| Quarter ending Mar 31, 2027 | -$2.23 | -$2.18 | -$2.18 | -$2.18 | -$2.20 | N/A |
Frequently Asked Questions About NXTC
What is the NXTC stock forecast?
Consensus analyst estimates put NextCure's EPS at -$6.34 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from NXTC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$6.34, with estimates from -$6.34 to -$6.34 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$5.90, with estimates from -$10.41 to -$1.38 from 2 analysts.
How many analysts cover NXTC?
1 analyst estimates EPS for NextCure for the fiscal year ending Dec 31, 2026.
NXTC pages: Overview, Earnings, Forecast, Financials, Competitors